Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
22,186,446
-
Share change
-
-1,152,295
-
Total reported value
-
$84,417,545
-
Put/Call ratio
-
193%
-
Price per share
-
$3.80
-
Number of holders
-
67
-
Value change
-
-$7,838,003
-
Number of buys
-
33
-
Number of sells
-
21
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q3 2019
As of 30 Sep 2019,
KALA BIO INC COM NEW - Stock (KALA) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,186,446 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, BlackRock Inc., CAXTON CORP, WELLINGTON MANAGEMENT GROUP LLP, Athyrium Capital Management, LP, Polaris Venture Management Co. V, L.L.C., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.